✦ LIBER ✦

T1127 Adalimumab Safety in Patients with Crohn's Disease and Previous Exposure to Infliximab: CHOICE Trial

✍ Scribed by Lichtiger, Simon; Binion, David G.; Wolf, David C.; Present, Daniel H.; Lomax, Kathleen G.; Kent, Jeffrey D.; Cardoso, Alexandra T.; Lau, Winnie

Book ID: 123327792
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 101 KB
Volume: 134
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)62287-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Su1127 In Patients With Crohn's Disease,

Su1127 In Patients With Crohn's Disease, Timing of Switching From Infliximab Maintenance Therapy to Adalimumab Affects Patients' Prognosis

✍ Takeuchi, Ken; Yamada, Akihiro; Suzuki, Yasuo 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 211 KB

T1061 Improvement in Short Inflammatory

T1061 Improvement in Short Inflammatory Bowel Disease Questionnaire Scores in Adalimumab-Treated Crohn's Disease Patients Who Failed Infliximab (CHOICE Trial)

✍ Lichtiger, Simon; Present, Daniel H.; Wu, Eric; Beaulieu, Nicolas; Kent, Jeffrey 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 226 KB

T1062 Improvement in Work Productivity w

T1062 Improvement in Work Productivity with Adalimumab in Crohn's Disease Patients Who Failed Prior Infliximab: An Analysis of the CHOICE Trial

✍ Lichtiger, Simon; Present, Daniel H.; Persson, Bjorn; Wu, Eric; Kent, Jeffrey D. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Switch to adalimumab in patients with Cr

Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial

✍ Van Assche, G.; Vermeire, S.; Ballet, V.; Gabriels, F.; Noman, M.; D'Haens, G.; 📂 Article 📅 2011 🏛 BMJ Publishing Group 🌐 English ⚖ 356 KB

Switch to adalimumab in patients with Cr

Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial

✍ Van Assche, G.; Vermeire, S.; Ballet, V.; Gabriels, F.; Noman, M.; D'Haens, G.; 📂 Article 📅 2011 🏛 BMJ Publishing Group 🌐 English ⚖ 356 KB

## Background: Elective switching between anti-tumour necrosis factor (tnf) agents not necessarily dictated by efficacy or tolerability occurs in clinical practice. a study was undertaken to evaluate prospectively the impact of elective switching of patients with crohn's disease well controlled wit

P104 - Safety and efficacy of adalimumab

P104 - Safety and efficacy of adalimumab in a patient with refractory Crohn's disease and previous severe infliximab hepatotoxicity. A case report

✍ I. Puig; A. Villoria; X. Calvet; V. Puig Diví; P. Garcia 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 49 KB